BioTech
ZBH

Zimmer Biomet Announces FDA Clearance For Enhanced Version Of ROSA Knee System

November 14, 2025 — 07:46 am EST

Written by RTTNews.com for RTTNews->

(RTTNews) - Zimmer Biomet Holdings, Inc. (ZBH) announced FDA 510(k) clearance of ROSA Knee with OptimiZe, an enhanced version of its ROSA Knee System. Zimmer Biomet will conduct a targeted release of ROSA Knee with OptimiZe later in the current year with commercial availability in the U.S. expected in the first quarter of 2026.

ROSA Knee with OptimiZe personalizes the surgeon's experience with customized intelligent surgical planning and new positioning, tracking and alignment features. The technology provides a simplified user interface that allows surgeons to choose the information they want to see, when they want to see it.

For More Such Health News, visit rttnews.com.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

BioTech
RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source->

Stocks mentioned

ZBH

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

  • •

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.